Profile avatar
drsarahsammons.bsky.social
Breast Medical Oncologist and researcher Interested in patient centric approaches to improve outcomes Associate Director Metastatic Breast Program Dana Farber Cancer Institute Harvard Medical School #oncsky #cansky #medsky
88 posts 1,238 followers 525 following
Prolific Poster

Boswellia aka Indian frankincense or olibanum, is a tree native to India. In a clinical trial, it was safe and effective for radiation induced necrosis of brain metastases which is a common problem! #medsky www.redjournal.org/article/S036...

Medicare stops access to #Telehealth April 1st for almost all. [Even rural pts must drive to a 🏥 office 1st & THEN get telehealth.] This will lead to: 1️⃣ less access to specialty care 2️⃣ poorer outcomes 3️⃣ higher costs for people with cancer #Telemedicine was a step forward. Let's not fall back.

It matters that scientists speak out against what is being done to US science. Staying silent is neither "objective" nor "staying out of politics". Silence now *is* political - it supports the status quo, says "nothing to worry about". We need to sound the alarm. www.nature.com/articles/d41...

In a 2023 ASCO survey, 60% of US oncologists report burnout. <25% are happy with work-life integration. Higher rates in caregivers and those <50. 20% plan to reduce clinical hours. #medsky pubmed.ncbi.nlm.nih.gov/39906334/

7year intracranial PFS 42% with 1st line Ipi/Nivo for melanoma with asymptomatic brain mets Incredible progress. Increasingly paradigm in met melanoma not truly palliative, but long term disease control. Challenge remains to increase rate of durable responses #medsky #Oncsky #melanoma

Since federal health information is getting harder to come by, I thought I'd share this new resource. Cornell's College of Veterinary Medicine launched an online Avian Flu Resource Center--a one-stop clearinghouse for trustworthy information on bird flu. www.vet.cornell.edu/highly-patho...

Treatment Algorithm series: discussion on HER2+ #BreastCancer ✅ APT data/TCHP ✅ Metastatic disease ✅ Her2/ER/PR+ Full discussion: ⭐️ oncbrothers.com/her2positive... ⭐️ www.cancernetwork.com/treatment-al... ⭐️ “Oncology Brothers” podcast #bcsm #CancerSky #OncSky @drsarahsammons.bsky.social

This is so smart. @petebuttigieg.bsky.social , thoughts ? And if you see this. A reminder. This is not Twitter. You can engage here and have thoughtful discussions ! We all look forward to reading your thoughts

This new Administration is a bunch of terrorists blowing up all that is meant to keep us safe and healthy. CDC cuts expected to devastate Epidemic Intelligence Service, a ‘crown jewel’ of public health www.statnews.com/2025/02/14/t... via @statnews.com

Yes

Check out the newest #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (February 3rd-9th, 2025). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch

It is not a coincidence that the authoritarian regimes around the world attack universities with full force (Erdogan, Orban, Wilders, Tories, Trump, you name it). As long as academic institutions comply and bow down, they are bound to lose. journals.openedition.org/ejts/8114

On changes to #NIH indirect rates, there is a law in place that prohibits NIH from making such changes without the approval of Congress. See Division D, Title II Section 224 of The Further Consolidated Appropriations Act, 2024 (Public Law No: 118-47) grants.nih.gov/grants/guide...

1. Today the NIH director issued a new directive slashing overhead rates to 15%. I want to provide some context on what that means and why it matters. grants.nih.gov/grants/guide...

#NIH just slashed indirect costs caps on grants to 15%--this is a HUGE blow to the research community. While there is certainly inefficiency to the grants system, indirects help institutions support scientists & academic infrastructure. No one will want to do research anymore. #medsky #academicsky

Congratulations all!! @stolaney1.bsky.social @lymphomadoc.bsky.social @ryannipp.bsky.social and more! #FASCO

The silence is deafening.

Recognizing the brilliant #WomenInMedicine today 2/3/25 who continue to persevere, break glass ceilings and improve healthcare #NWPD25 #IamBlackwell @quirogad.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @drsgraff.bsky.social @drsarahsammons.bsky.social @maryamlustberg.bsky.social

On the holy grail of biology "The A.I. virtual cell (AIVC) has the potential to revolutionize the scientific process, leading to future breakthroughs in biomedical research, personalized medicine, drug discovery, cell engineering,& programmable biology” @science.org www.science.org/doi/10.1126/...

this is how it feels to reach 30 MILLION users!!!

Two competing hospital systems coming together to serve the needs of the children in North Carolina! Unprecedented and Commendable. www.beckershospitalreview.com/capital/duke...

T-Dxd approved as first line chemo in HR+, HER2 low or ultra low disease. Do all patients need it first line? Probably not. But great option for higher risk. #bcsm #oncosky

This is huge. The European equivalent to the FDA has said enough to the propaganda machine X. Others will follow. #medsky #oncosky www.reuters.com/world/europe...

www.msnbc.com/all-in/watch...

Factor VIII gene was introduced into hematopoietic stem cells in men with hemophilia. The annualized bleeding rate went from 10 to 0. No worrisome gene integrations were seen. Read the full correspondence: nej.md/3PIZ4iX #MedSky #Hematology

Rates of #cancer in #young #adults have risen dramatically in recent years - as discussed in this article.. We urgently need to invest in #research 🧪 on early-onset cancers to understand - why? www.theguardian.com/science/2025...

What do you eat after cancer? www.dailymail.co.uk/health/artic...

DEI is not the same as diversity in clinical trials. Diversity in clinical trials aims to test new drugs in a wide variety of people, because response to some medicines can vary by gender, age, ethnicity, and genetics. www.statnews.com/2025/01/23/f...

Confession: I LOVE hyponatremia 🤓 (I know, I know. What can I say, I'm a true internist!) HypoNa is often feared, maligned, and misunderstood - but I promise it doesn't have to be scary! Here are my top 10 hyponatremia tips and tricks - a 🧵 #emimcc

What a terrible week for science and equity. 😭 www.reuters.com/business/hea...

Fantastic thread about why freezing the NIH has far reaching consequences.

Medical advances mean many more people are surviving cancer and living for years or decades with its after effects. Here's how they are navigating life after treatment.

Confusion and anxiety are rippling through the US health-research community this week after Trump's team abruptly cancelled grant reviews at NIH, the world’s largest public biomedical funder Read my story for @nature.com, w/ @labonnelab.bsky.social, @choo.bsky.social: www.nature.com/articles/d41...

Welcome immigrants from X interested in science to the friendlier skies of @bsky.app, as documented by a new @nature.com survey (but you already knew that 😉) "Bluesky is much better for science. There is much less toxicity, misinformation, and distractions." www.nature.com/articles/d41...

Update. I prescribed Palbo yesterday to my first patient on HP plus letrozole maintenance for MBC since Oct. Immediate approval.

We are thrilled to share the amazing presenters we have assembled for our MBC conference on March 8th in New Haven, CT. Register here: mbcc2025.givesmart.com @maryamlustberg.bsky.social @lizoriordan.bsky.social @marthacarlson.bsky.social @itsnotpink.bsky.social @drsarahsammons.bsky.social

The Infinite Strength Annual Gala is our largest event of the year and we are so thrilled to announce our keynotes @maryamlustberg.bsky.social @drsarahsammons.bsky.social @markrobsonmd.medsky.social and Robert Legare. Tickets become available Feb. 1 #bcsm

Interesting endpoint and trial. Few MBC patients treated and very small. For oligoprogressive cancer, SBRT could delay time to systemic therapy change. This could could valuable for the right patient trying to delay time to chemotherapy. www.redjournal.org/article/S036...

New JCO 📰 #Abemaciclib Plus #Fulvestrant in Advanced #BreastCancer Following Progression on CDK4/6 Inhibition: Results from the postMONARCH Trial 🔓https://pubmed.ncbi.nlm.nih.gov/39693591/ ✍️ @erikahamilton9.bsky.social @drsgraff.bsky.social @drsarahsammons.bsky.social @bastien-nguyen.bsky.social

Dato-Dxd approved in Metastatic HR+, HER-neg Breast Cancer. Same payload as T-Dxd and bit less potent. Unknown activity after T-Dxd or saci. Could consider for true HER2- zero as first line chemo or in subsequent lines. #bcsm www.targetedonc.com/view/fda-app...

UnitedHealth has overcharged some cancer patients for medicine by over 1,000%. An FTC report finds that OptumRx, United Health's pharmacy benefit manager, has made billions by charging patients a huge markup for life-saving drugs. www.yahoo.com/news/unitedh...

A top three problem in healthcare facing our generation. #medsky www.nejm.org/doi/full/10....

Don't miss this recent review outlining practical treatment strategies and novel therapies in the PI3K/AKT/mTOR pathway in HR+/HER2- advanced #BreastCancer 🔓 pubmed.ncbi.nlm.nih.gov/39674130/ @antgiordanomd.bsky.social @drtimothyerick.bsky.social @stolaney1.bsky.social @drsarahsammons.bsky.social